GlassScriptPhysician profile
Patricia Tan
NPI 1821086737
$1,367.60
in general payments reported to CMS, 2019-2025
11 companies · $159 in 2025
The $159 reported for 2025 was more than what a typical Pediatric Rehabilitation Medicine provider received nationally (typical 2025 total: $109).
See the full distribution for Pediatric Rehabilitation Medicine
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $502 · 2020: $92.77 · 2021: $170 · 2022: $77.89 · 2023: $253 · 2024: $112 · 2025: $159.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $525.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $524.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $339.70 | 2023-2025 | Botox |
| Medtronic USA, INC. | $164.33 | 2019 | |
| Medtronic, INC. | $162.12 | 2021-2024 | Synchromedii |
| Insmed, INC. | $149.73 | 2023 | Arikayce |
| Ptc Therapeutics, INC. | $144.47 | 2019-2022 | |
| Biogen, INC. | $112.30 | 2019 | |
| Ipsen Biopharmaceuticals, INC | $94.22 | 2019-2025 | Dysport |
| Saol Therapeutics INC. | $88.15 | 2019-2020 | |
| Sarepta Therapeutics, INC. | $48.08 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $33.36 | 2022 | |
| Janssen Pharmaceuticals, INC | $31.14 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patricia Tan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.